Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer

Authors

  • Michael C. Repka Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • Thomas P. Kole Department of Radiation Oncology, The Valley Health Hospital, Ridgewood, NJ, USA
  • Jacqueline Lee Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • Binbin Wu Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Siyuan Lei Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • Thomas Yung Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • Brian T. Collins Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • Simeng Suy Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • Anatoly Dritschilo Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
  • John H. Lynch Department of Urology, Georgetown University Hospital, Washington, DC, USA
  • Sean P. Collins Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA

DOI:

https://doi.org/10.1080/0284186X.2017.1299221

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2017-08-03

How to Cite

Repka, M. C., Kole, T. P., Lee, J., Wu, B., Lei, S., Yung, T., … Collins, S. P. (2017). Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncologica, 56(8), 1136–1138. https://doi.org/10.1080/0284186X.2017.1299221

Issue

Vol. 56 No. 8 (2017): Acta Oncologica

Section

Articles